HOLOXAN 1g powder infusion solution medication leaflet

L01AA06 ifosfamide • Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues

Ifosfamide is a chemotherapy medication used to treat various types of cancer, including sarcomas, lymphomas, and testicular cancer. It belongs to the class of alkylating agents and works by interfering with the DNA of cancer cells, thereby inhibiting their growth and division.

The medication is administered via intravenous infusion under the supervision of an oncologist.

Side effects may include nausea, vomiting, hair loss, decreased blood cell counts, or hemorrhagic cystitis. In rare cases, severe allergic reactions or kidney dysfunction may occur.

Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should not use this medication.

General data about HOLOXAN 1g

Substance: ifosfamide

Date of last drug list: 10-04-2026

Commercial code: W70295001

Concentration: 1g

Pharmaceutical form: powder infusion solution

Quantity: 1

Product type: original

Price: 178.15 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BAXTER ONCOLOGY GMBH - GERMANIA

Holder: BAXTER HEALTHCARE S.R.L. - ROMANIA

Number: 11919/2019/01

Shelf life: 5 years-after packaging for sale; after reconstituting the solution: 24 hours

Concentrations available for ifosfamide

1g, 2g, 500mg

Compensation lists for HOLOXAN 1g BAXHESRL

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

178.15 RON

178.15 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

178.15 RON

178.15 RON

0.00 RON